EMEA Presenting at the 74th session of the World Health Organisation Committee for Europe
EMEA News for October 2024
In 2023 the European ME Alliance received
‘
official Non-State Actor accreditation’ status
from WHO’s Regional Office for Europe during WHO Europe’s 73rd Regional
Committee Meeting (RC73).
This status permits EMEA to participate in WHO Europe Regional Meetings and
to make official statements on agenda topics of interest.
EMEA aims to use this platform to improve awareness, recognition, and action for Myalgic Encephalomyelitis (ME) across
WHO Europe’s 53 member states.
EMEA statement at 74th Regional Committee Meeting for Europe on the
agenda item 12
Harnessing innovation for public health in the WHO European Region 2025–2030: preparing for a new strategy
This was the final statement delivered by the European ME Alliance at the 74th Regional Committee Meeting for Europe on the topic of a Harnessing innovation for public health in the WHO European Region 2025–2030: preparing for a new strategy .
"an innovative solution can be creating Centers of Excellence within existing research parks, staffed with interdisciplinary teams for both research and clinical care. Examples of such developing centers exist in the UK, Norway, and Sweden, and are currently funded mainly by European ME Alliance members."
Read the full statement here.
Further Reading:
- WHO Europe Message for International ME Conference Week Delegates
- EMEA Presenting at the 74th session of the World Health Organisation Committee for Europe
- EMEA statement at 74th Regional Committee Meeting for Europe on the agenda item discussing the State of Health in the WHO European Region
- EMEA statement at 74th Regional Committee Meeting for Europe on the agenda item 8 European regional action framework for behavioural and cultural insights for equitable health, 2022–2027
- EMEA statement at 74th Regional Committee Meeting for Europe on the agenda item 9 Framework for resilient and sustainable health systems in the WHO European Region 2025–2030
- EMEA statement at 74th Regional Committee Meeting for Europe on the agenda item 12 Harnessing innovation for public health in the WHO European Region 2025–2030: preparing for a new strategy
